Eitan Amir

Has grant

Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Evaluation of Myocardial changes during BReast Adenocarcinoma therapy to detect Cardiotoxicity Earlier with MRI- The EMBRACE-MRI Study

Open Date: 2015-07-01

Close Date: 2019-06-30

Grant: Close

Evaluation of Myocardial changes during BReast Adenocarcinoma therapy to detect Cardiotoxicity Earlier with MRI- The EMBRACE-MRI Study

Open Date: 2014-10-01

Close Date: 2015-09-30

Grant: Close

Evaluation of Myocardial changes during BReast Adenocarcinoma therapy to detect Cardiotoxicity Earlier with MRI- The EMBRACE-MRI Study

Open Date: 2014-03-01

Close Date: 2015-02-28

Grant: Close

What is the role of comorbidity, frailty and functional status in the decision-making process for older adults with cancer and their family members, cancer specialist, and family physician?

Open Date: 2013-08-01

Close Date: 2015-07-31

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Michael Barton

UNSW

AUSTRALIA

View details

Eric X Chen

University Health Network

CANADA

View details

Oscar Calvillo-Argüelles

Assistant Professor

NOSM University

CANADA

View details

Brooke Wilson

CANADA

View details

Arnoud Templeton

University of Basel

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eitan Amir

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis

Changes in circulating tumor DNA and outcomes in solid tumors treated with immune checkpoint inhibitors: a systematic review

Three-year disease-free survival in randomized trials of neoadjuvant chemotherapy and HER2-targeted therapy in breast cancer: A meta-analysis

Clinical benefit of cancer drugs approved in Switzerland 2010–2019

Optimism Bias in the Design of Phase III Randomized Control Trials Evaluating PD-1/PD-L1 Targeting Monoclonal Antibodies

Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer

Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer

Are NCCN Resource-Stratified Guidelines for Breast Cancer Systemic Therapy Achievable? A Population-Based Study of Global Need and Economic Impact

Prognostic factors for relapse in resected gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis

Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis

Collaborators (5)

Michael Barton

Eric X Chen

Oscar Calvillo-Argüelles

Brooke Wilson

Arnoud Templeton

Make your next move.